Testing effectiveness (Phase 2)Ended earlyNCT03572634
What this trial is testing
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
Who this might be right for
Chronic Lymphocytic LeukemiaCLLSLL+1 more
Sumitomo Pharma America, Inc. 3